Rhythm Pharma
Commercial-stage biopharma specializing in rare neuroendocrine diseases, with IMCIVREE (setmelanotide) in Phase 3 for obesity syndromes; backed by licensing deals with LG Chem, Ipsen, Camurus, and joint research with Axovia.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 283
- HQ: Boston
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.